atai Life Sciences (ATAI) Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)

Go back to atai Life Sciences (ATAI) Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)

atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)

August 13, 2024 7:00 AM EDT

VLS-01 is designed to induce a short psychedelic experience, allowing for a total in-clinic treatment of 2-hours, consistent with an established commercial paradigm in interventional psychiatryVLS-01 reached peak plasma concentration within 30-45 minutes and was shown to induce a short psychedelic experience, with subjective effects generally resolving within 90-120 minutesVLS-01... More